MiNK Therapeutics Inc. logo

MiNK Therapeutics Inc.

INKT | NASDAQ
Chart Builder DCF Calculator
$12.10
-$0.15 (-1.22%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Cash & Equivalents
8.81B 9.53M 13.36M 14.28M 1.68M 3.23M 4.58M 6.33M 9.31M 5.82M 3.37M 6.4M 10.62M 14.89M 19.64M 24.16M 29.85M 34.69M 38.89M 819.45K 1.66M n/a
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
318.47M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0 0 0 0 0 0 n/a 2.56M 0 n/a
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 23K 35K n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
489.79M 232.26K 211.2K 32 55.21K 108.71K 164.24K 11.2K 61.14K 122.48K 177.96K 29.34K 166.03K 320.89K 470.3K 37.52K 378.13K 604.64K 721.32K 10.87K 2.37M -2.69M
Total Current Assets
9.3B 10.02M 13.85M 14.53M 2.01M 3.58M 4.99M 6.58M 9.47M 6M 3.6M 6.47M 11.05M 15.52M 20.4M 24.46M 30.33M 35.48M 39.63M 878.55K 4.2M n/a
Property-Plant & Equipment
n/a 354.52K 390.87K 429.34K 473.22K 687.5K 732.93K 799.52K 849.96K 894.99K 953.98K 991.46K 1.06M 1.07M 1.07M 803.13K 787.54K 665.21K 606.6K 635.89K 552.48K n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
318.47M 354.52K 390.87K 429.34K 473.22K 687.5K 732.93K 799.52K 849.96K 894.99K 953.98K 991.46K 1.06M 1.07M 1.07M 803.13K 787.54K 665.21K 606.59K 3.2M 552.48K n/a
Total Assets
9.62B 10.38M 14.24M 14.96M 2.48M 4.27M 5.72M 7.37M 10.32M 6.89M 4.55M 7.46M 12.11M 16.59M 21.47M 25.26M 31.12M 36.14M 40.24M 4.08M 4.75M n/a
Account Payables
3.92B 3.39M 3.43M 3.69M 3.31M 2.66M 2.73M 2.36M 3.2M 3.49M 3.91M 4.28M 4.89M 6M 5.82M 5.17M 4.79M 3.73M 3M 1.65M 2.27M n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a 5.18M 5.73M 5.51M 5.12M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 65.42M 52.53M n/a
Other Current Liabilities
7.57B 3.53M 2.85M 2.76M 2.48M 2.37M 2.36M 4.13M 6.94M 2.34M 5.66M 2.27M 2.33M 2.49M 5.21M 10.44M 9.79M 12.45M 12.89M 13.13M 10.3M n/a
Total Current Liabilities
7.57B 7.29M 13.03M 13.43M 13.16M 12.12M 6.96M 7.4M 10.15M 11.11M 11.4M 10.39M 11.46M 11.25M 12.68M 18.45M 17.43M 18.83M 16.47M 80.56M 67.55M n/a
Long-Term Debt
n/a n/a n/a n/a n/a n/a 4.92M 4.61M 4.41M 4.21M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 15.78M 15.44M 15.04M 14.51M 13.94M 13.42M 12.92M 12.35M 11.87M 11.21M 10.65M 10.14M 9.81M 9.19M 58.28K n/a 0 n/a 27.54K 383.06K 53.87M
Total Long-Term Liabilities
n/a 15.78M 15.44M 15.04M 14.51M 13.94M 18.35M 17.53M 16.75M 16.08M 11.21M 10.65M 10.14M 9.81M 9.19M 58.28K n/a 0 n/a 27.54K 383.06K 53.87M
Total Liabilities
n/a 23.06M 28.47M 28.48M 27.67M 26.06M 25.31M 24.93M 26.9M 27.19M 22.61M 21.04M 21.61M 21.06M 21.87M 18.51M 17.43M 18.83M 16.47M 80.59M 67.93M 53.87M
Total Debt
n/a n/a 5.18M 5.73M 5.51M 5.12M 4.92M 4.61M 4.41M 4.21M n/a n/a n/a n/a n/a n/a n/a n/a n/a 65.42M 52.53M n/a
Book Value
9.62B -12.69M -14.23M -13.51M -25.19M -21.79M -19.59M -17.55M -16.58M -20.3M -18.06M -13.58M -9.5M -4.48M -401.3K 6.76M 13.69M 17.31M 23.78M -76.51M -63.18M -53.87M
Book Value Per Share
1.91K -2.64 -3.33 -3.04 -6.33 -5.50 -5.19 -4.44 -4.46 -5.86 -5.22 -3.94 -2.76 -1.32 -0.12 2 4.07 5.17 7.23 -23.28 -22.25 -18.97
Common Stock
52K 51 48 46 40 40 40 395 394 347 346 345 345 343 339 338 337 336 335 242 87 n/a
Retained Earnings
-162.55B -159.42M -156.68M -154.07M -151.19M -146.95M -144.18M -141.72M -139.91M -137.21M -133.4M -127.94M -122.82M -116.63M -110.94M -103.17M -96.84M -90.72M -82.95M -77.18M -62.92M n/a
Comprehensive Income
-699.89M -697.43K -718.92K -692.11K -719.32K -662.44K -631.58K -672.84K -611.38K -385.78K -430.95K -313.19K -401.81K -373.8K -292.47K -78.28K 1.3M -102.5K -625.27K -789.34K -1.34M -53.87M
Shareholders Equity
n/a -12.69M -14.23M -13.51M -25.19M -21.79M -19.59M -17.55M -16.58M -20.3M -18.06M -13.58M -9.5M -4.48M -401.3K 6.76M 13.69M 17.31M 23.78M -76.51M -63.18M -53.87M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.